Skip to content
healthcare.dev

Regranex Gel 0.01%

NDC 85822-734, Becaplermin gel 0.01%, gel, from LRM Therapeutics, LLC.

Product NDC
85822-734
Status
Listed
Labeler
LRM Therapeutics, LLC
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103691
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85822-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BECAPLERMIN.1 mg/g

Pharmacologic classes

Human Platelet-derived Growth Factor [EPC]; Platelet-Derived Growth Factor [CS]

Package NDCNDC-11Package
85822-734-158582207341515 g in 1 TUBE (85822-734-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/377b3021-13d7-96d5-e063-6394a90a8ca3

Use it

Look up 85822-734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85822-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85822-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.